Hayase, Tomo

A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

Stein-Thoeringer, C. K., Saini, N. Y., Zamir, E., Blumenberg, V., Schubert, M.-L., Mor, U., Fante, M. A., Schmidt, S., Hayase, E., Hayase, T., et al. (2023) · Nature Medicine

CAR-T cell therapy researchGut microbiota and health

Cited by 255

Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis

Halsey, T. M., Thomas, A. S., Hayase, T., Ma, W., Abu-Sbeih, H., Sun, B., Parra, E. R., Jiang, Z.-D., DuPont, H. L., Sanchez, C., et al. (2023) · Science Translational Medicine

Cancer Immunotherapy and BiomarkersGut microbiota and health

Cited by 161

Association of μ-opioid receptor gene (OPRM1) haplotypes with postoperative nausea and vomiting

Sugino, S., Hayase, T., Higuchi, M., Saito, K., Moriya, H., Kumeta, Y., Kurosawa, N., Namiki, A., & Janicki, P. K. (2014) · Experimental Brain Research

Nausea and vomiting managementPharmacogenetics and Drug Metabolism

Cited by 28